Screening

Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.

Two-tiered MRI approach for headache cuts costs 40 percent

Neuroimaging for patients complaining of a headache is largely discouraged because few abnormalities are found. Using an abbreviated MRI sequence to determine which patients need to proceed to a comprehensive scan, however, can generate savings of more than 40 percent for payers while still catching problems at a high rate, according to a study published in the July issue of the American Journal of Roentgenology.

Siemens Announces FDA Clearance of Virtual Touch Elastography Imaging

Siemens Healthcare, a pioneer in ultrasound innovation, has announced that the Food and Drug Administration (FDA) has cleared the company’s Virtual Touch imaging ultrasound application – Siemens’ first commercially available implementation of Acoustic Radiation Force Impulse (ARFI) technology.

MDs override guidelines: Kids w/ headache often referred for CT

Physicians are bucking the recommendations from multiple specialty societies against the use of neuroimaging for many children presenting with headaches, researchers reported in a study published June 24 in Pediatrics. Although they are common offenders, emergency room physicians aren’t the only providers who appear to be guilty of inappropriate use.

Healthcare Agrees to Acquire Certain Assets of Rayence, a Subsidiary of Vatech, Acknowledging Korea’s Technology in Mammography

GE Healthcare (NYSE: GE) today announced that it has agreed to acquire certain Mammography assets of Rayence, a subsidiary of Vatech Co Ltd (KOSDAQ: 043150), a Korean X-Ray manufacturer. The Mammography assets of Rayence will, at closing, become part of the Detection & Guidance Solutions (DGS) business unit of GE Healthcare.

iCAD Receives FDA Approval for FujiFilm Aspire HD Digital Mammography System

iCAD, Inc. (NASDAQ: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced approval by the U.S. Food and Drug Administration (FDA) for use of the Company’s SecondLook® mammography computer-aided detection (CAD), on the next generation PowerLook Advanced Mammography Platform (AMP)™, for FujiFilm’s Aspire™ HD Full-Field Digital Mammography System.

fMRI reveals 2 Gulf War Illness phenotypes

In an unanticipated finding, George Washington University researchers discovered two distinct phenotypes of Gulf War Illness. An exercise challenge showed one subgroup with orthostatic tachycardia and a second with exercise-induced hyperalgesia, according to a study published online June 14 in PLOS One. 

San Antonio Hospital Installs Eight CARESTREAM DR Systems To Help Lower Dose, Speed Image Access

San Antonio Community Hospital (Upland, Calif.) installed eight wireless CARESTREAM DRX Systems to deliver instant image access and other capabilities that can enhance patient care at its 279-bed acute care hospital.

Mindray to Acquire ZONARE Medical Systems

Mindray Medical International Limited (NYSE: MR), today announced a definitive agreement to acquire ZONARE Medical Systems, Inc. (ZONARE), an ultrasound technology leader in the high-end radiology segment for US$105 million. Mindray’s management expects the deal to strengthen its high-end ultrasound R&D and U.S. sales capabilities, furthering the company’s goal of becoming a leading provider of high-quality imaging products to markets worldwide.

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.